You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FOLFIRI failure

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial in Madrid (Aflibercept, Irinotecan, folinic acid (dl racemic))

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Madrid, Spain
    Spanish Cooperative Group for Digestive Tumour Therapy (TTD)
Oct 10, 2022

Neuroendocrine Carcinomas Trial in France (Folfiri-bevacizumab, Folfiri)

Recruiting
  • Neuroendocrine Carcinomas
  • Amiens, France
  • +26 more
Jan 26, 2022

Unresectable Colon Cancer Peritoneal Metastases, PMMR/Ras/BRAF Wild-type Trial in Huzhou (Serplulimab Combined With FOLFIRI and

Recruiting
  • Unresectable Colon Cancer Peritoneal Metastases
  • PMMR/Ras/BRAF Wild-type
  • Serplulimab Combined With FOLFIRI and Bevacizumab
  • Huzhou, Zhejiang, China
    Changxing County People's Hospital
Feb 14, 2023

Advanced Gastric Cancer Trial in Seoul (oxaliplatin, 5-fluorouracil)

Completed
  • Advanced Gastric Cancer
  • oxaliplatin, 5-fluorouracil
  • Seoul, Korea, Republic of
    Asan medical center
Jan 6, 2020

Metastatic Colorectal Cancer Trial in Denmark, Germany, Spain (FOLFIRI Protocol, SCO-101)

Recruiting
  • Metastatic Colorectal Cancer
  • Aalborg, Denmark
  • +11 more
Feb 28, 2022

Colorectal Cancer Trial in Madrid (FOLFOX regimen, Panitumumab, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • FOLFOX regimen
  • +3 more
  • Madrid, Spain
    Spanish Cooperative Group for the Treatment of Digestive Tumors
Mar 8, 2022

Colorectal Cancer Trial in Worldwide (Napabucasin, Fluorouracil, Leucovorin)

Completed
Has Results
  • Colorectal Cancer
  • Birmingham, Alabama
  • +210 more
Mar 30, 2022

Pancreatic Ductal Adenocarcinoma, Locally Advanced Cancer, Metastatic Cancer Trial in France (FOLFIRI, OSE2101)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Amiens, France
  • +27 more
Oct 19, 2021

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Germany (Cetuximab, FOLFIRI)

Active, not recruiting
  • Adenocarcinoma of the Colon
  • Adenocarcinoma of the Rectum
  • Bochum, Germany
  • +3 more
Oct 14, 2021

Metastatic Colorectal Cancer Trial in Milan (Capecitabine, Temozolomide, Irinotecan)

Completed
  • Metastatic Colorectal Cancer
  • Milan, Mi, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Sep 3, 2021

Colorectal Tumors, Colorectal Carcinoma, Colorectal Cancer Metastatic Trial in Spain (Panitumumab, Irinotecan, Folinic acid)

Completed
  • Colorectal Neoplasms
  • +3 more
  • L'Hospitalet de Llobregat, Barcelona, Spain
  • +11 more
Jun 18, 2021

MSI-H Advanced Colorectal Cancer Trial in Tianjin (Pembrolizumab (PD-1 Inhibitor) Combined With Bevacizumab and FOLFIRI Regimen)

Recruiting
  • MSI-H Advanced Colorectal Cancer
  • Pembrolizumab (PD-1 Inhibitor) Combined With Bevacizumab and FOLFIRI Regimen
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Sep 3, 2021

Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8, Clinical Stage IVB Gastric Cancer AJCC v8

Recruiting
  • Clinical Stage IV Gastric Cancer AJCC v8
  • +26 more
  • Biopsy
  • +10 more
  • Duarte, California
  • +2 more
Jan 25, 2023

Colorectal Cancer, Metastatic Cancer Trial in Boulogne Billancourt (FOLFIRI regimen, fluorouracil, irinotecan HCl)

Withdrawn
  • Colorectal Cancer
  • Metastatic Cancer
  • FOLFIRI regimen
  • +7 more
  • Boulogne Billancourt, France
    Hopital Ambroise Pare
Aug 26, 2022

Gastric Adenocarcinoma, Gastric Cancer Trial in France (Durvalumab, Tremelimumab, FOLFIRI Protocol)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Gastric Cancer
  • Abbeville, France
  • +34 more
Jun 17, 2021

Gastric Cancer Trial in France (Irinotecan associated to fluorouracil and leucovorin)

Completed
Has Results
  • Gastric Cancer
  • Irinotecan associated to fluorouracil and leucovorin
  • Bordeaux, France
  • +5 more
Sep 16, 2021

Colorectal Cancer Metastatic Trial in Ireland, United States (Regorafenib (BAY 73-4506), FOLFIRI, Placebo)

Completed
Has Results
  • Colorectal Cancer Metastatic
  • Regorafenib (BAY 73-4506)
  • +2 more
  • Denver, Colorado
  • +23 more
Dec 10, 2020

Colorectal Cancer Trial in Hangzhou (Ametumumab, Anti-PD-1 mAb, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
Jan 30, 2023

Metastatic Colorectal Cancer Trial in Iran, Islamic Republic of (Bevacizumab + FOLFIRI-3)

Completed
Has Results
  • Metastatic Colorectal Cancer
  • Bevacizumab + FOLFIRI-3
  • Ahvaz, Iran, Islamic Republic of
  • +21 more
Dec 30, 2020

Cholangiocarcinoma Trial in Düsseldorf (Combination of Lonsurf® and Irinotecan)

Recruiting
  • Cholangiocarcinoma
  • Combination of Lonsurf® and Irinotecan
  • Düsseldorf, NRW, Germany
    Klinik für Gastroenterologie, Hepatologie und Infektiologie
Dec 22, 2022

Metastatic Colorectal Cancer Trial in Toronto (Hydroxychloroquine, Irinotecan, Leucovorin)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 24, 2023

Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma, Advanced Gastric Carcinoma Trial in United States

Recruiting
  • Advanced Colorectal Carcinoma
  • +42 more
  • Duarte, California
  • +9 more
Jan 21, 2023

Vectibix With Chemotherapy for Metastatic Colorectal Cancer

Completed
Has Results
  • Wild-type RAS Metastatic Colorectal Cancer
  • Panitumumab + Chemotherapy
  • (no location specified)
Nov 4, 2022

Unresectable or Metastatic Colorectal Cancer Trial in Shenyang (FOLFOX/FOLFIRI)

Recruiting
  • Unresectable or Metastatic Colorectal Cancer
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital & Institute
Mar 22, 2023

Metastatic Microsatellite-stable Colorectal Cancer Trial in China (Experimental drug, Control Rx)

Recruiting
  • Metastatic Microsatellite-stable Colorectal Cancer
  • Experimental drug
  • Control Rx
  • Hefei, Anhui, China
  • +11 more
Mar 13, 2023